A new Mac infostealer dubbed PamStealer impersonates the open-source Maccy clipboard manager to steal passwords and more.

Jamf says the Rust-based PamStealer targets Apple Silicon Macs, steals browser, wallet, Keychain, and clipboard data, and persists.

The new PamStealer Mac malware appears to be surprisingly clever while it harvests data and login credentials in the ...

Researchers have found a never-before-seen piece of macOS malware that combines a series of clever tradecraft to infect Macs ...

Apps from Apple, Google and others can assist in making your online accounts more secure, even as new ways of logging in continue to take off. By J. D. Biersdorfer J.D. Biersdorfer writes about how to ...

UPDATE: May. 6, 2026, 9:40 a.m. EDT This piece was updated to include a statement from Microsoft. Password managers are supposed to make life easier for users by remembering their passwords and ...

We wouldn't blame you for assuming that AI, being a computer, would be better at generating passwords than a human. After all, people use AI to do everything from writing their emails to generating a ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Max Eddy Max Eddy is a writer who has covered privacy and security — including ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Jake Peterson is Lifehacker’s Tech Editor, and has been covering tech news and how-tos for nearly a decade. His team covers all things technology, including AI, smartphones, computers, game consoles, ...

The era of AI has not been particularly great for cybersecurity. We know that vibe-coded websites and apps have been a hotbed of security flaws that leave the platforms vulnerable to attacks. It turns ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...